Vilanterol trifenatate
Important Notice: For research use only. We do not sell to patients.
Not your Region? View all Distributors
Important Notice: For research use only. We do not sell to patients.
Not your Region? View all Distributors
Discription | Vilanterol is a long-acting beta-2 agonist drug, which in May 2013 was approved in combination with fluticasone furoate for sale as Breo Ellipta by GlaxoSmithKline for the treatment of chronic obstructive pulmonary disease (COPD). |
---|
Catalog Num | A15998 |
---|---|
Formula | C44H49Cl2NO7 |
Molecular Weight | 774.8 |
CAS Number | 503070-58-4 |
SMILES | C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)O.C1=CC(=C(C(=C1)Cl)COCCOCCCCCCNC[C@@H](C2=CC(=C(C=C2)O)CO)O)Cl |
Synonyms | GW642444, GW-642444, GW 642444X |
Storage | Store lyophilized at -20ºC, keep desiccated. |
In vitro | DMSO | 86 mg/mL (111 mM) | |
Water | Insoluble | ||
Ethanol | 12 mg/mL | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 12.91 mL | 64.53 mL | 129.07 mL |
0.5 mM | 2.58 mL | 12.91 mL | 25.81 mL |
1 mM | 1.29 mL | 6.45 mL | 12.91 mL |
5 mM | 0.26 mL | 1.29 mL | 2.58 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2